Hone Health is targeting longevity care.
The latest: The telemedicine clinic secured $33M in Series A funding from investors including Tribe Capital and PIF.
Acquiring in-home healthcare provider ivee, it plans to expand beyond hormonal optimization.
Market momentum. Established as a men’s health clinic, Hone has tested 300K patients and treated 55K to date — pairing lifestyle interventions with TRT and other supplements.
Leveraging telehealth framework, regulatory and compliance expertise, and a vast global hormone dataset, Hone is expanding into proactive longevity care — for men and women.
Stacked. CEO Saad Alam says the shift could reshape how patients approach care, and life.
“When you look at the world of primary care, longevity, and wellness, they’re essentially becoming one category.”
Targeting reversals of chronic conditions like diabetes, CVD, cancer, and dementia while expanding research on menopause, Hone intends to personalize “stacks” for optimal longevity, including Rx medications, nine forthcoming supplements, and recovery protocols.
Meanwhile, the ivee acquisition adds in-home services like IV therapy and phlebotomy, enabling direct-to-patient care delivery.
Takeaway: Connecting hormonal health and longevity medicine through a comprehensive EMR, Hone is shifting its focus to upgrade traditional telehealth.